Concerns growing over another price cuts in blockbuster drugs

Published: 2013-01-02 06:59:00

Updated: 2013-01-02 06:59:00

The government’s plan to re-price the drugs that exceed their initial sales forecasts in the first half of next year has triggered concerns from the industry.

Under the current regulation, drug manufacturers and the National Health Insurance Corporation (NHIC) will be called to discuss the vol...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK